Gema
Jiménez

Gema Jiménez González is a Associate Professor at the Department of Human Anatomy and
Embryology of the University of Granada (UGR) and a member of the Research Group
“Advanced Therapies: differentiation, regeneration, and cancer” (CTS-963). She holds a
Degree in Biology and a Master’s in Regenerative Biomedicine from the University of
Granada, where she also obtained her Ph.D. in Biomedicine with International Mention,
Outstanding Cum Laude distinction, and the Extraordinary Doctoral Thesis Award. Her scientific
career integrates regenerative biomedicine, cancer biology, and bioengineering, focusing on
the interplay between cancer stem cells (CSCs) and the 3D microenvironment to develop
translational models and therapeutic strategies.
Her research is centered on the design of biomaterials, bioinks, and bioprinted multicellular
systems that recreate the complexity of native tissues and tumors, enabling the study of CSC
dynamics and their role in therapy resistance and tumor regeneration. Through the
combination of 3D bioprinting, nanotechnology, and molecular biology, she has contributed
to the development of functionalized matrices for tissue regeneration and advanced tumor
models incorporating CSCs, providing novel tools for understanding tumor heterogeneity and
testing targeted therapies.
Gema has authored of more than 50 publications in high-impact journals and holds several
patents derived from her work in biofabrication, tissue engineering, and cancer modeling.
She has taken part in 37 research projects (3 European and 16 national), serving as Principal
Investigator in 5. Her leadership within translational research has consolidated a
multidisciplinary platform connecting basic science, clinical application, and technology
transfer.
She maintains active collaborations with academic and industrial partners, including Regemat
3D, BEOnChip, Bioibérica, Breca Healthcare, PKR-exogenetics, 3DBiotech, DestiNAGenomica,
3B´s Research Group and Leartiker, fostering translational innovation and biomedical
entrepreneurship. She serves as reviewer and guest editor for several leading international
journals (Cells, Cancers, International Journal of Bioprinting) and is a Secretary of the Chair Drs.
Galera and Requena of Cancer Stem Cell Research and Cátedra interuniversitaria Celia
Bujaldón de Investigación en Cáncer (UGR), and member of the Spanish Network of
Therapeutic Advances (TERAV, Ministry of Science and Innovation), and the European
Network for Skin Engineering and Modeling (NETSKIN, EU COST 21 Action).
Her scientific contributions have been recognized with several awards, including those for Best
Oral Communication, Best Poster, and the Social Council Award of the University of Granada.
Within the CTS-963 group, designated as a Singular Laboratory by the University of Granada,
she leads interdisciplinary projects that integrate advanced therapies, biomaterials, 3D
bioprinting, and CSC biology, while actively mentoring young researchers in the field of
biomedical sciences.

BACK TO PEOPLE